EUCTR2011-003176-36-IT进行中（未招募）不适用
Individualizing duration of antibiotic therapy in hospitalized patients with community-acquired pneumonia: a non-inferiority, randomized, controlled trial.
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO0 个研究点目标入组 892 人开始时间: 2011年12月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 892
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Diagnosis of pneumonia
- •2) Having received an 'adequate empirical antibiotic therapy for pneumonia within 24 hours of admission to hospital.
- •3) have achieved clinical stability within 5 days of hospitalization, in the absence of changes to the initial empirical antibiotic therapy.
- •4) Have signed the informed consent
- •5)> 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 92
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 800
排除标准
- •1) patients with immune deficiency, defined as: chemotherapy in the previous 12 months, radiotherapy in the previous 12 months, transplantation, immunosuppressive treatment, haematological malignancy, AIDS or HIV infection with CD4 counts <200, asplenia.
- •2) Patients with other concomitant infection at the time of hospitalization that requires antibiotic treatment.
- •3) Patients with documented bacteremia with S. aureus.
- •4) Patients with pneumonia caused by fungi, mycobacteria, or Pneumocystis jiroveci
研究者
相似试验
进行中（未招募）
不适用
Optimal duration of antibiotic treatment in patients with complicated parapneumonic pleural effusions or empyemaDuration of antibiotic treatment in complicated parapneumonic pleural effusion and empyema.EUCTR2014-003137-25-ESJosé Manuel Porcel Pérez Hospital Arnau de Vilanova de Lleida Servicio Medicina Interna
终止
不适用
STudy of Antibiotic Treatment In Children with chronic cough (STATIC)ISRCTN88611534Royal Stoke University Hospital80
进行中（未招募）
1 期
Assess the optimal duration of pneumonia antibiotic treatmentCommunity Acquired PneumoniaMedDRA version: 20.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaSystem Organ Class: 100000004862EUCTR2017-001406-15-ESFundació Clínic per la Recerca Biomèdica424
进行中（未招募）
1 期
Short versus extended antibiotic treatment for fever during low white blood cell counts in hematology patients with fever of unknown origin.Febrile neutropeniaMedDRA version: 19.1Level: PTClassification code 10063581Term: Stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: LLTClassification code 10002969Term: Aplastic anemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.1Level: LLTClassification code 10003999Term: BacteremiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10007810Term: Catheter related infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10028566Term: MyelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10062957Term: Catheter bacteraemiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10024329Term: LeukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: PTClassification code 10056520Term: Catheter site infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-001546-25-NLVU University Medical Center240
已完成
4 期
Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiority trial.febrile neutropenia1001886510004018NL-OMON47609VUmc276